Insider Transactions in Q4 2015 at Prothena Corp Public LTD CO (PRTA)
Insider Transaction List (Q4 2015)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 09
2015
|
Tran Nguyen Chief Strategy Officer and CFO |
SELL
Open market or private sale
|
Direct |
30,000
-52.1%
|
$1,980,000
$66.28 P/Share
|
|
Dec 09
2015
|
Tran Nguyen Chief Strategy Officer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+48.23%
|
$180,000
$6.73 P/Share
|
|
Dec 09
2015
|
Gene G. Kinney President and CEO |
SELL
Open market or private sale
|
Direct |
30,000
-46.96%
|
$1,980,000
$66.29 P/Share
|
|
Dec 09
2015
|
Gene G. Kinney President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+47.78%
|
$180,000
$6.41 P/Share
|
|
Dec 09
2015
|
Tara Nickerson Chief Business Officer |
SELL
Open market or private sale
|
Direct |
10,000
-39.22%
|
$660,000
$66.25 P/Share
|
|
Dec 09
2015
|
Tara Nickerson Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+45.45%
|
$60,000
$6.73 P/Share
|
|
Dec 01
2015
|
Dennis J. Selkoe |
SELL
Open market or private sale
|
Direct |
3,125
-21.13%
|
$215,625
$69.0 P/Share
|
|
Dec 01
2015
|
Dennis J. Selkoe |
BUY
Exercise of conversion of derivative security
|
Direct |
3,125
+34.36%
|
$50,000
$16.42 P/Share
|
|
Nov 27
2015
|
Christopher S Henney Director |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$375,000
$75.0 P/Share
|
|
Nov 27
2015
|
Christopher S Henney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$30,000
$6.65 P/Share
|
|
Nov 25
2015
|
Lars Ekman |
SELL
Open market or private sale
|
Direct |
30,000
-75.93%
|
$2,190,000
$73.71 P/Share
|
|
Nov 25
2015
|
Lars Ekman |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+49.8%
|
$180,000
$6.41 P/Share
|
|
Nov 19
2015
|
Dale B. Schenk President and CEO |
BUY
Bona fide gift
|
Indirect |
3,333
+18.3%
|
-
|
|
Nov 19
2015
|
Dale B. Schenk President and CEO |
SELL
Bona fide gift
|
Direct |
3,333
-100.0%
|
-
|
|
Nov 17
2015
|
Dale B. Schenk President and CEO |
SELL
Open market or private sale
|
Direct |
30,000
-33.23%
|
$2,010,000
$67.7 P/Share
|
|
Nov 17
2015
|
Dale B. Schenk President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
33,333
+50.0%
|
$199,998
$6.03 P/Share
|
|
Nov 13
2015
|
Martin Koller Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
30,000
-100.0%
|
$1,950,000
$65.03 P/Share
|
|
Nov 13
2015
|
Martin Koller Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+50.0%
|
$180,000
$6.73 P/Share
|
|
Nov 02
2015
|
Arthur W Homan Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,125
-100.0%
|
$162,500
$52.14 P/Share
|
|
Nov 02
2015
|
Arthur W Homan Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,125
+50.0%
|
$68,750
$22.14 P/Share
|
|
Oct 29
2015
|
Christopher S Henney Director |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$275,000
$55.0 P/Share
|
|
Oct 29
2015
|
Christopher S Henney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$30,000
$6.65 P/Share
|